PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of TWD 165.85 billion. The enterprise value is 145.77 billion.

Market Cap	165.85B
Enterprise Value	145.77B

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

PharmaEssentia has 333.04 million shares outstanding. The number of shares has increased by 3.59% in one year.

Current Share Class	n/a
Shares Outstanding	333.04M
Shares Change (YoY)	+3.59%
Shares Change (QoQ)	+2.05%
Owned by Insiders (%)	8.86%
Owned by Institutions (%)	10.22%
Float	256.15M

Valuation Ratios

The trailing PE ratio is 56.08 and the forward PE ratio is 32.64.

PE Ratio	56.08
Forward PE	32.64
PS Ratio	17.04
PB Ratio	6.04
P/TBV Ratio	6.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 70.32, with an EV/FCF ratio of 86.52.

EV / Earnings	49.16
EV / Sales	14.97
EV / EBITDA	70.32
EV / EBIT	83.96
EV / FCF	86.52

Financial Position

The company has a current ratio of 9.94, with a Debt / Equity ratio of 0.04.

Current Ratio	9.94
Quick Ratio	9.34
Debt / Equity	0.04
Debt / EBITDA	0.47
Debt / FCF	0.57
Interest Coverage	78.23

Financial Efficiency

Return on equity (ROE) is 11.54% and return on invested capital (ROIC) is 4.05%.

Return on Equity (ROE)	11.54%
Return on Assets (ROA)	3.72%
Return on Invested Capital (ROIC)	4.05%
Return on Capital Employed (ROCE)	6.09%
Revenue Per Employee	74.31M
Profits Per Employee	22.64M
Employee Count	131
Asset Turnover	0.33
Inventory Turnover	0.86

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +70.61% in the last 52 weeks. The beta is 0.19, so PharmaEssentia's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+70.61%
50-Day Moving Average	580.84
200-Day Moving Average	625.45
Relative Strength Index (RSI)	40.20
Average Volume (20 Days)	1,678,652

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of TWD 9.73 billion and earned 2.97 billion in profits. Earnings per share was 8.88.

Revenue	9.73B
Gross Profit	8.56B
Operating Income	1.74B
Pretax Income	2.99B
Net Income	2.97B
EBITDA	1.85B
EBIT	1.74B
Earnings Per Share (EPS)	8.88

Full Income Statement

Balance Sheet

The company has 21.05 billion in cash and 965.43 million in debt, giving a net cash position of 20.09 billion or 60.31 per share.

Cash & Cash Equivalents	21.05B
Total Debt	965.43M
Net Cash	20.09B
Net Cash Per Share	60.31
Equity (Book Value)	27.47B
Book Value Per Share	82.52
Working Capital	22.86B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.55 billion and capital expenditures -862.00 million, giving a free cash flow of 1.68 billion.

Operating Cash Flow	2.55B
Capital Expenditures	-862.00M
Free Cash Flow	1.68B
FCF Per Share	5.06

Full Cash Flow Statement

Margins

Gross margin is 87.91%, with operating and profit margins of 17.83% and 30.46%.

Gross Margin	87.91%
Operating Margin	17.83%
Pretax Margin	30.76%
Profit Margin	30.46%
EBITDA Margin	18.97%
EBIT Margin	17.83%
FCF Margin	17.31%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.23%.

Dividend Per Share	1.10
Dividend Yield	0.23%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.59%
Shareholder Yield	-3.36%
Earnings Yield	1.79%
FCF Yield	1.02%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 29.21.

Altman Z-Score	29.21
Piotroski F-Score	n/a